PharmaTher Holdings Ltd.
PHRRF
$0.135
-$0.0143-9.58%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.48% | -16.91% | -30.46% | -6.95% | -13.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -64.07% | -76.75% | -65.92% | -49.02% | 10.30% |
| Operating Income | 64.07% | 76.75% | 65.92% | 49.02% | -10.30% |
| Income Before Tax | 65.53% | 72.25% | 77.48% | 51.69% | 54.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 65.53% | 72.25% | 77.48% | 51.69% | 54.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.53% | 72.25% | 77.48% | 51.69% | 54.14% |
| EBIT | 64.07% | 76.75% | 65.92% | 49.02% | -10.30% |
| EBITDA | 64.08% | 76.75% | 65.91% | 49.00% | -10.30% |
| EPS Basic | 65.91% | 72.57% | 77.44% | 50.79% | 54.17% |
| Normalized Basic EPS | 63.04% | 77.14% | 65.45% | 47.50% | -17.95% |
| EPS Diluted | 65.91% | 72.57% | 77.44% | 50.79% | 54.17% |
| Normalized Diluted EPS | 63.04% | 77.14% | 65.45% | 47.50% | -17.95% |
| Average Basic Shares Outstanding | 0.40% | 0.40% | 0.26% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.40% | 0.40% | 0.26% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |